Seite - 123 - in Advances in Neuroimmunology

BrainSci. 2016,6, 23 References 1. Antinori, A.; Arendt, G.; Becker, J.T.; Brew, B.J.; Byrd, D.A.; Cherner, M.; Clifford, D.B.; Cinque, P.; Epstein,L.G.;Goodkin,K.; etal.UpdatedresearchnosologyforHIV-associatedneurocognitivedisorders. Neurology2007,69, 1789–1799. [CrossRef] [PubMed] 2. Heaton, R.K.; Franklin, D.R.; Ellis, R.J.; McCutchan, J.A.; Letendre, S.L.; LeBlanc, S.; Corkran, S.H.; Duarte,N.A.;Clifford,D.B.;Woods,S.P.HIV-associatedneurocognitivedisordersbeforeandduringtheera of combinationantiretroviral therapy:Differences in rates,nature, andpredictors. J.Neurovirol. 2011,17, 3–16. [CrossRef] [PubMed] 3. Tozzi, V.; Balestra, P.; Bellagamba, R.; Corpolongo,A.; Salvatori,M.F.; Visco-Comandini,U.; Vlassi, C.; Giulianelli,M.;Galgani,S.;Antinori,A.; etal. Persistenceofneuropsychologicdeficitsdespite long-term highlyactiveantiretroviral therapy inpatientswithHIV-relatedneurocognitive impairment: Prevalenceand risk factors. J.Acquir. ImmuneDefic. Syndr. 2007,45, 174–182. [CrossRef] [PubMed] 4. Chen, Y.; An, H.; Zhu, H.; Stone, T.; Smith, J.K.; Hall, C.; Bullitt, E.; Shen, D.; Lin, W. White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage2009,47, 1154–1162. [CrossRef] [PubMed] 5. Gosztonyi,G.;Artigas, J.;Lamperth,L.;Webster,H.D.Humanimmunodeficiencyvirus (HIV)distribution in HIVencephalitis: Studyof19caseswithcombineduseof insituhybridizationandimmunocytochemistry. J.Neuropathol. Exp.Neurol. 1994,53, 521–534. [CrossRef] [PubMed] 6. Zou,S.;Fuss,B.;Fitting,S.;Hahn,Y.K.;Hauser,K.F.;Knapp,P.E.Oligodendrocytesare targetsofHIV-1 tat: Nmdaandampareceptor-mediatedeffectsonsurvivalanddevelopment. J.Neurosci. 2015,35, 11384–11398. [CrossRef] [PubMed] 7. DelValle, L.; Croul, S.;Morgello, S.;Amini, S.; Rappaport, J.; Khalili,K.DetectionofHIV-1 tat and JCV capsidprotein,VP1, inAIDSbrainwithprogressivemultifocal leukoencephalopathy. J.Neurovirol. 2000,6, 221–228. [CrossRef] [PubMed] 8. Bellizzi,A.;Nardis,C.;Anzivino,E.;Rodio,D.;Fioriti,D.;Mischitelli,M.;Chiarini,F.;Pietropaolo,V.Human polyomavirus JCreactivationandpathogeneticmechanismsofprogressivemultifocal leukoencephalopathy andcancer in theeraofmonoclonalantibodytherapies. J.Neurovirol. 2012,18, 1–11. [CrossRef] [PubMed] 9. Hauser,K.F.;Hahn,Y.K.;Adjan,V.V.;Zou,S.;Buch,S.K.;Nath,A.;Bruce-Keller,A.J.;Knapp,P.E.HIV-1 tat andmorphinehave interactiveeffectsonoligodendrocytesurvivalandmorphology.Glia2009,57, 194–206. [CrossRef] [PubMed] 10. Li,R.;Mi,H.;Zhao, J.;Yuan,D.;Ding, J.;Li,H.WhitematterdamageandeffectsofnadirCD4+counton patientswithasymptomaticHIVassociateddementia complex–ADTI study. Radiol. Infect. Dis. 2014,1, 11–16. [CrossRef] 11. Bernardo,A.;Agresti,C.;Levi,G.HIV-gp120affects the functionalactivityofoligodendrocytesandtheir susceptibility tocomplement. J.Neurosci. Res. 1997,50, 946–957. [CrossRef] 12. Kimura-Kuroda, J.;Nagashima,K.;Yasui,K. Inhibitionofmyelin formationbyHIV-1gp120 inratcerebral cortexculture.Arch.Virol. 1994,137, 81–99. [CrossRef] [PubMed] 13. Nukuzuma,S.;Kameoka,M.;Sugiura,S.;Nakamichi,K.;Nukuzuma,C.;Miyoshi, I.;Takegami,T.Exogenous humanimmunodeficiencyvirus-1protein, tat, enhancesreplicationof JCvirusefficiently inneuroblastoma cell lines. J.Med.Virol. 2012,84, 555–561. [CrossRef] [PubMed] 14. Radja, F.; Kay, D.G.; Albrecht, S.; Jolicoeur, P. Oligodendrocyte-specific expression of human immunodeficiency virus type 1 NEF in transgenic mice leads to vacuolar myelopathy and alters oligodendrocytephenotype invitro. J.Virol. 2003,77, 11745–11753. [CrossRef] [PubMed] 15. Correa,D.G.;Zimmermann,N.;Doring,T.M.;Wilner,N.V.;Leite,S.C.;Cabral,R.F.;Fonseca,R.P.;Bahia,P.R.; Gasparetto,E.L.Diffusiontensormrimagingofwhitematter integrityinHIV-positivepatientswithplanning deficit.Neuroradiology2015,57, 475–482. [CrossRef] [PubMed] 16. Gongvatana,A.;Schweinsburg,B.C.;Taylor,M.J.;Theilmann,R.J.;Letendre,S.L.;Alhassoon,O.M.; Jacobus,J.; Woods,S.P.; Jernigan,T.L.;Ellis,R.J.; etal.Whitematter tract injuryandcognitive impairment inhuman immunodeficiencyvirus-infected individuals. J.Neurovirol. 2009,15, 187–195. [CrossRef] [PubMed] 17. Uban, K.A.; Herting, M.M.; Williams, P.L.; Ajmera, T.; Gautam, P.; Huo, Y.; Malee, K.M.; Yogev, R.; Csernansky, J.G.;Wang, L.; et al. Whitemattermicrostructure amongyouthwithperinatally acquired HIVisassociatedwithdiseaseseverity.AIDS2015,29, 1035–1044. [CrossRef] [PubMed] 123